Search Results
((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)tris(dimethylamino)phosphonium hexafluorophosphate(V) 500g | 98%
BLD Pharmatech Ltd.
((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)tris(dimethylamino)phosphonium hexafluorophosphate(V) 10g | 98%
BLD Pharmatech Ltd.
((1R,2R,3S,4S)-2-((Tert-Butyldimethylsilyl)Oxy)-3-Fluoro-4-((4-Methoxybenzyl)Oxy)Cyclopentyl)Methanol inquiry | 0.95%
Alfa Chemistry
((1R,2R,3S)-2,3-Bis((diphenylphosphino)methyl)-1,2-dimethylcyclopentyl)methanol inquiry | 98%
Alfa Chemistry
((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-Dioxooctahydro-2H-4,7-methanoisoindol-2-yl)methyl)cyclohexyl)methyl 4-(benzo[d]isothiazol-3-yl)piperazine-1-carboxylate Please inquire | >95%
BOC Sciences
((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl 4-(benzo[d]isothiazol-3-yl)piperazine-1-carboxylate Please inquire | >95%
BOC Sciences
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine 25mg | ≥95%
Musechem
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine Please inquire | Purity Not Available
BOC Sciences
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine is an intermediate int he synthesis of Tasimelteon (T007740), a novel drug, used in the treatment of non-24 hour sleep-wake disorder. It helps to correct the circadian rhythm disorder often seen in patients who are visually impaired.
More Information Supplier Page